# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-22T16:35:02.756703

---

**Idea Fidelity**

The submitted paper clearly pursues the original concept outlined in the manifest: it studies the link between GP practice closures and A&E utilization in England, uses NHS ODS data for closure dates, and focuses on causal inference with staggered timing. However, there are departures worth noting. The manifest emphasized a Callaway–Sant’Anna (CSA) event-study estimator and a patient-list or GP-workforce mechanism; the paper instead relies on a standard two-way fixed effects (TWFE) model with a binary ``post-closure’’ indicator, reports very little on mechanism, and never implements the CSA estimator it promised. Likewise, while the manifest highlighted heterogeneity by deprivation and distance to surviving practices, the paper limits heterogeneity analysis to geographic regions (with distance only implicitly through the 10 km buffer). A fuller engagement with the promised estimation strategy and mechanism tests would strengthen fidelity to the original idea.

---

**Summary**

The paper analyzes more than 2,400 GP practice closures between 2017 and 2025 and estimates their effect on Type 1 A&E attendances across 122 NHS trusts using a staggered difference-in-differences framework. The main result is a statistically insignificant 3.2 percent increase in attendances post-closure, but the effect becomes a significant 6.6 percent rise in the post-COVID period, suggesting that the emergency-room cost of losing primary-care access materializes only when the NHS is under severe strain. The paper interprets the findings through patient absorption, alternative pathways, and demand suppression channels.

---

**Essential Points**

1. **Credibility of Identification Strategy.** While the staggered nature of GP closures is promising, the causal claims rest on a TWFE regression with a binary post-treatment indicator and rely heavily on the parallel-trends assumption. The paper states that a Sun–Abraham event study was estimated, but no figure or coefficients are reported; without this, it is impossible to evaluate whether pre-trends or heterogeneity in treatment timing bias the TWFE estimate. Please present the event-study plot (and underlying coefficients) so readers can assess pre-treatment dynamics, and clarify whether the TWFE estimates survive more robust estimators such as CSA or stacked DiD. Given the very small number of never-treated trusts (3) and the ubiquity of treatment, the paper should address how “not-yet-treated” controls are used, whether timing of closures is exogenous to trust-level shocks, and how they avoid contamination from treatment effect heterogeneity.

2. **Measurement of Treatment and Exposure.** The treatment indicator triggers sharply once any GP within 10 km closes, yet closures differ in size, patient load, and whether they were followed by a merger. Aggregating all closures into a single binary variable risks misclassification: a closure of a very small or already-merging practice may have negligible effect, while closure of a large GP surgery serving tens of thousands could be consequential but treated the same. Please provide evidence that the 10 km buffer captures actual changes in patient access (e.g., distribution of closure sizes, patient lists, or proximity to the next surviving GP). In addition, consider using a treatment intensity measure (e.g., total patient list affected or practice list size) and report results with this specification. This would help to assess whether the null effect reflects averaging over large heterogeneity in treatment dosage.

3. **Interpretation of the Post-COVID Effect.** The finding of a significant post-COVID effect is striking, but the current evidence is thin. The paper distinguishes pre- and post-COVID periods exogenously, yet trusts treated after 2022 may have very different closure types or patient composition, and the pandemic itself disrupted both treatment timing and outcomes. Please test whether the structural break is robust to (i) controlling for time-varying trust-level characteristics (e.g., local population growth, deprivation, or COVID pressure indicators) and (ii) estimating an interaction of the closure indicator with a continuous measure of system strain (e.g., average waiting time or bed occupancy). Moreover, the narrative would benefit from a placebo test showing that the post-COVID effect is not driven by differential trends among late-treated trusts before treatment occurs.

If these three issues cannot be addressed convincingly, the paper may not meet the standard for publication; otherwise, the contribution is potentially important.

---

**Suggestions**

1. **Implement the Promised Event-Study Estimator.** You mention estimating a Sun–Abraham event study but do not present the coefficients or plot. Please include the dynamic coefficients (ideally with two-sided confidence intervals) so readers can assess the pre-trend. Since the idea manifest prioritized the Callaway–Sant’Anna estimator, consider running it explicitly (with never-treated and not-yet-treated controls as appropriate) and reporting ATT by event time. This will demonstrate robustness to heterogeneous treatment timing and motivate the TWFE results.

2. **Enrich the Treatment Definition.** The 10 km radius is a reasonable starting point but could be fine-tuned. Consider exploiting postcodes to compute actual patient displacement: for each closure, estimate how many GP patients lived within trust catchment and whether they switched to another practice or remained unregistered. If patient-list data are unavailable, proxy for exposure using practice list size (from NHS Digital appointments data) or GP Full-Time Equivalent (FTE) statistics to weight closures. Another option is to define treatment based on the nearest surviving GP distance after closure or to incorporate travel time to the next available surgery. These refinements help establish that any effect (or lack thereof) is not driven by measurement error.

3. **Augment Control Variables.** Although trust and month fixed effects absorb time-invariant and national shocks, area-level determinants such as population aging, socio-economic change, or hospital capacity investments could confound the estimates. If possible, construct time-varying controls at the trust level—e.g., local population (from ONS), deprivation indices, or proxy for demand via GP registrations—and include them in the regression (or interact them with post-closure). At minimum, discuss why these factors are unlikely to bias the results and show sensitivity analyses (e.g., controlling for linear time trends by region or including lagged outcomes).

4. **Explore Alternative Outcomes.** To understand mechanisms better, supplement the main analysis with secondary outcomes: total A&E attendances (already partially shown), GP appointment wait times, urgent treatment centre visits, or NHS 111 call volumes if data permit. Evidence that GP closures did not shift demand to these other urgent-care outlets would support the “null” explanation. Likewise, examine whether GP closures affected mortality or hospital admissions for GP-manageable conditions (if data are available) to test the “demand suppression” channel.

5. **Strengthen the Post-COVID Narrative.** The conclusion that the emergency room tax “switches on” post-COVID would be more persuasive if you tied it to concrete measures of system strain. For example, add a plot showing how the post-COVID period differs in average waiting times or outpatient backlogs. Alternatively, interact the closure indicator with trust-level metrics of capacity (e.g., four-hour target performance, ambulance turnaround times) to see if the effect is concentrated where the system was already under stress. This would convert the descriptive pre/post split into a testable hypothesis about resilience.

6. **Clarify Mechanisms Through Qualitative or Auxiliary Data.** The Discussion section hypothesizes patient absorption, alternative pathways, and demand suppression, but there is no direct evidence. If possible, link closures to GP registration statistics (changes in list size for nearby practices) or GP workforce data to show whether surviving surgeries actually expanded capacity. If not, explicitly acknowledge these as conjectures and identify data that could be collected in future work.

7. **Address Statistical Power and Precision.** The main coefficient has a large standard error relative to its point estimate. It would help to report the minimum detectable effect size given your sample (for example, using the clustered standard errors). Mention how many trust-month observations are newly treated each month and whether the variation is concentrated in certain years, as this affects inference. If the post-COVID effect is driven by a handful of late closures, clarify this and consider presenting cluster-robust inference with wild bootstrap as a sensitivity check.

8. **Document the Spatial Assignment Process.** The appendix could include maps or summary tables showing the geographic distribution of treated trusts and closures, perhaps differentiated by urban/rural status. This would illustrate whether the analysis disproportionately reflects dense areas (where 10 km contains many practices) or rural ones.

9. **Transparency on Data and Code.** Since the paper is part of an autonomous project, share details on data cleaning, geocoding accuracy (e.g., proportion of closures with valid postcodes), and how missing data are handled. Make the code repository easily accessible and ideally include sample scripts for reproducing key tables.

Overall, the paper addresses an important question with rich data, but solidifying the identification strategy and refining the treatment measurement will make the contribution far more credible and informative for policy.
